As ri­vals stum­ble, Pfiz­er boasts of a sec­ond 'break­through' on PhI­II RSV vac­cine

Pfiz­er has picked up fresh brag­ging rights for its big RSV vac­cine dri­ve.

The phar­ma gi­ant to­day spot­light­ed its sec­ond break­through drug des­ig­na­tion for PF …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.